Johnny Stilou
Financieel Directeur/CFO bij SCANDION ONCOLOGY A/S
Oorsprong van het eerstegraads netwerk van Johnny Stilou
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 32 | |
| Public Company | Pharmaceuticals: Major | 18 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Johnny Stilou via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| HERON THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Sapphire Therapeutics, Inc.
 Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member President | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| GN STORE NORD A/S | Telecommunications Equipment | Corporate Officer/Principal Director/Board Member | |
EG A/S
 EG A/S Packaged SoftwareTechnology Services EG A/S provides information technology solutions. It offers solutions for electronic business, customer relationship management, supply chain management, business intelligence, portals, and electronic document management. The firm serves the transport, textile, timber yard, construction, and industrial markets. It also provides operations solutions, service and support, business process outsourcing, application development, infrastructure, hardware and software; mobile solutions and information technology courses; and sector specific systems. The company was founded in 1977 and is headquartered in Herning, Denmark. | Packaged Software | Director/Board Member | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Chief Executive Officer | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | President Corporate Officer/Principal | |
Arkitema K/S
 Arkitema K/S Engineering & ConstructionIndustrial Services Arkitema K/S provides architecture and consulting services. Its architecture service focuses on market segments such as housing, business, health, learning, culture, and urban. The consulting service offers specialized and consulting services in construction management, sustainability, people involvement, building information modelling management, and client consultancy. The company was founded in 1969 and is headquartered in Aarhus, Denmark. | Engineering & Construction | Chairman | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree | |
Symbion A/S
 Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark. | General Government | Director/Board Member Chairman | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| OCATA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
KLIFO A/S
 KLIFO A/S Miscellaneous Commercial ServicesCommercial Services KLIFO A/S provides clinical research services. Its services include development plans, protocols, project management, monitoring, data management and statistics, reporting, regulatory affairs, importing, packaging, labeling, and distribution of clinical trials. The company provides services to the pharmaceutical and medical devices industries. KLIFO was founded by Dr. Allan Rosetzsky in 1994 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer Chairman | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Graduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| University of Southern Denmark | College/University | Graduate Degree Corporate Officer/Principal | |
Dubex A/S
 Dubex A/S Information Technology ServicesTechnology Services Dubex A/S provides information technology services. The firm specializes in consulting and implementing solutions focusing on Internet, security, and mobility. Dubex also offers maintenance and monitoring services. The company was founded in 1997 and is headquartered in Copenhagen, Denmark. | Information Technology Services | Chairman | |
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| CORNERSTONE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member Comptroller/Controller/Auditor Corporate Officer/Principal | |
| Life Cycle Pharma A/S | Chairman Chief Executive Officer | ||
| WNTRESEARCH AB | Pharmaceuticals: Other | Chief Executive Officer General Counsel | |
Lyngsoe Systems A/S
 Lyngsoe Systems A/S Miscellaneous Commercial ServicesCommercial Services Lyngsoe Systems A/S is a holding company that provides logistics solutions. It develops software and systems integrators of logistics solutions for logistics chain environments. The firm designs, installs, and maintains control and track-and-trace systems within the radio frequency identification technology. Its businesses cover postal, airport, supply chain, controls, and library solutions. The company was founded on September 1, 1994 and is headquartered in Aars, Denmark. | Miscellaneous Commercial Services | Chairman | |
COWI Holding A/S
 COWI Holding A/S Engineering & ConstructionIndustrial Services COWI Holding A/S engages in providing engineering and consulting services. The firm through its subsidiaries provides consultancy services within the fields of engineering, environmental science and economics. Its subsidiaries offer consultancy services for infrastructure such as bridges, tunnels, marine structures, airports, and mapping. The company was founded in 2010 and is headquartered in Kongens Lyngby, Denmark. | Engineering & Construction | Director/Board Member | |
Velux A/S
 Velux A/S Forest ProductsNon-Energy Minerals Velux A/S manufactures building materials. Its products include roof windows, modular skylights, sun tunnels, decorative elements, blinds, roller shutters, installation solutions, ventilations, and remote controls. The company was founded by Villum Kann Rasmussen in 1941 and is headquartered in Horsholm, Denmark. | Forest Products | Director of Finance/CFO | |
| TREVI THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
AX IV EG Holding III ApS
 AX IV EG Holding III ApS MiscellaneousMiscellaneous AX IV EG Holding III ApS operates as a holding Danish company. The private company is based in Copenhagen, Denmark. | Miscellaneous | Director/Board Member | |
| IT-Branchen | Chairman | ||
Adactit ApS
 Adactit ApS Packaged SoftwareTechnology Services Adactit ApS provides information technology consulting and support services. It focuses on Microsoft Cloud, Azure, Intune and other individual solutions. The firm services include consulting, planning and implementation, customization, and managed and support services. The company was founded by Jesper Grønbæk in 2011 and is headquartered in Copenhagen, Denmark. | Packaged Software | Chairman | |
| Minerva A/S | Director/Board Member | ||
| Cc Track Holding A/S | Chairman | ||
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer Director/Board Member | |
| TERRASCEND CORP. | Agricultural Commodities/Milling | Director/Board Member Director/Board Member | |
Avenge Bio, Inc.
 Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Avenge Bio, Inc. is an oncology-focused biotechnology company based in the United States. The American company develops cell-based immunotherapeutic products for the treatment of solid tumors using its proprietary Lococyte™ platform. The platform delivers engineered cells to the local tumor environment, generating high concentrations of immune effector molecules in proximity to the tumor, which initiates a robust, local, and durable systemic immune response while avoiding toxicities associated with systemic immunotherapies. Avenge's most advanced product candidate, AVB-001, produces native IL-2 immunotherapy and is initially being studied in metastatic peritoneal cancers such as ovarian cancer. The company has additional pipeline candidates for the treatment of a wide range of cancers, including pancreatic, lung, and breast cancers. Avenge was founded in 2019 by Paul Kevin Wotton and Michael Thomas Heffernan, with Heffernan serving as CEO since incorporation. | Pharmaceuticals: Major | Founder Founder |
Statistieken
Internationaal
| Denemarken | 28 |
| Verenigde Staten | 18 |
| Verenigd Koninkrijk | 2 |
| Noorwegen | 2 |
| Zwitserland | 2 |
Sectoraal
| Health Technology | 25 |
| Consumer Services | 6 |
| Technology Services | 5 |
| Finance | 4 |
| Miscellaneous | 3 |
Operationeel
| Director/Board Member | 246 |
| Corporate Officer/Principal | 101 |
| Chairman | 78 |
| Independent Dir/Board Member | 71 |
| Chief Executive Officer | 70 |
Sterkste connecties
| Insiders | |
|---|---|
| Jørgen Vilhelm Bardenfleth | 64 |
| Flemming Ørnskov | 34 |
| Mette Agger | 30 |
| Edward Penhoet | 29 |
| Paul Wotton | 27 |
| Christian Vinding Thomsen | 27 |
| Paul Edick | 27 |
| Thomas Dyrberg | 24 |
| Michael Heffernan | 23 |
| Craig Collard | 18 |
| Robert Radie | 18 |
| Kurt Anker Nielsen | 18 |
| Nils Aage Brünner | 17 |
| François Martelet | 16 |
| James New | 14 |
- Beurs
- Insiders
- Johnny Stilou
- Bedrijfsconnecties
